Inhibition of pluripotent stem cell-derived teratoma formation by small molecules

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 35, 2013, Pages

  Lee, Mi Ok ^a,g   Moon, Sung Hwan ^b   Jeong, Ho Chang ^a   Yi, Ji Yeon ^c   Lee, Tae Hee ^c   Shim, Sung Han ^b   Rhee, Yong Hee ^d   Lee, Sang Hun ^d   Oh, Seok Jeong ^e   Lee, Moo Yeol ^e   Han, Min Joon ^f   Cho, Yee Sook ^g   Chung, Hyung Min ^h   Kim, Kwang Soo ^f   Cha, Hyuk Jin ^a  

^a Sogang University   (South Korea)

^b CHA University   (South Korea)

^c Sejong University   (South Korea)

^d Hanyang University   (South Korea)

^e Dongguk University   (South Korea)

^f MCLEAN HOSPITAL   (United States)

^g Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^h Konkuk University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN BCL 10; PROTEIN BCL 2; PROTEIN P53; QUERCETIN; SEPANTRONIUM BROMIDE; SURVIVIN;

ACETYLATION; APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TERATOMA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION PROFILING; HUMANS; IMIDAZOLES; INHIBITOR OF APOPTOSIS PROTEINS; MITOCHONDRIA; NAPHTHOQUINONES; PLURIPOTENT STEM CELLS; SMALL MOLECULE LIBRARIES; STEM CELL TRANSPLANTATION; TERATOMA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84883386827     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1303669110     Document Type: Article

References (67)

1. Thomson JA, et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145-1147.
2. Takahashi K, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861-872.
3. Yu J, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917-1920.
4. Robinton DA, Daley GQ (2012) The promise of induced pluripotent stem cells in research and therapy. Nature 481(7381):295-305.
5. Klimanskaya I, Rosenthal N, Lanza R (2008) Derive and conquer: Sourcing and differentiating stem cells for therapeutic applications. Nat Rev Drug Discov 7(2):131-142.
6. Hanna JH, Saha K, Jaenisch R (2010) Pluripotency and cellular reprogramming: Facts, hypotheses, unresolved issues. Cell 143(4):508-525.
7. Yu J, Thomson JA (2008) Pluripotent stem cell lines. Genes Dev 22(15):1987-1997.
8. Blum B, Benvenisty N (2008) The tumorigenicity of human embryonic stem cells. Adv Cancer Res 100:133-158.
9. Miura K, et al. (2009) Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol 27(8):743-745.
10. Teng X, Keys H, Yuan J, Degterev A, Cuny GD (2008) Structure-activity relationship and liver microsome stability studies of pyrrole necroptosis inhibitors. Bioorg Med Chem Lett 18(11):3219-3223.
11. Teng X, et al. (2007) Structure-activity relationship study of [1,2,3]thiadiazole necroptosis inhibitors. Bioorg Med Chem Lett 17(24):6836-6840.
12. Hu X, Han W, Li L (2007) Targeting the weak point of cancer by induction of necroptosis. Autophagy 3(5):490-492.
13. Feng Q, et al. (2010) Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28(4):704-712.
14. Schuldiner M, Itskovitz-Eldor J, Benvenisty N (2003) Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells 21(3):257-265.
15. Chung S, et al. (2006) Genetic selection of sox1GFP-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation. J Neurochem 97(5):1467-1480.
16. Tang C, et al. (2011) An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat Biotechnol 29(9):829-834.
17. Choo AB, et al. (2008) Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1. Stem Cells 26(6): 1454-1463.
18. Knoepfler PS (2009) Deconstructing stem cell tumorigenicity: A roadmap to safe regenerative medicine. Stem Cells 27(5):1050-1056.
19. Qin H, et al. (2007) Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. J Biol Chem 282(8):5842-5852.
20. Wilson KD, et al. (2010) Effects of ionizing radiation on self-renewal and pluripotency of human embryonic stem cells. Cancer Res 70(13):5539-5548.
21. Hong Y, Cervantes RB, Tichy E, Tischfield JA, Stambrook PJ (2007) Protecting genomic integrity in somatic cells and embryonic stem cells. Mutat Res 614(1-2):48-55.
22. Han MK, et al. (2008) SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell 2(3): 241-251.
23. Filion TM, et al. (2009) Survival responses of human embryonic stem cells to DNA damage. J Cell Physiol 220(3):586-592.
24. Dumitru R, et al. (2012) Human embryonic stem cells have constitutively active Bax at the Golgi and are primed to undergo rapid apoptosis. Mol Cell 46(5):573-583.
25. Smith AJ, et al. (2012) Apoptotic susceptibility to DNA damage of pluripotent stem cells facilitates pharmacologic purging of teratoma risk. Stem Cells Transl Med 1(10): 709-718.
26. Guo Y, Mantel C, Hromas RA, Broxmeyer HE (2008) Oct-4 is critical for survival/antiapoptosis of murine embryonic stem cells subjected to stress: effects associated with Stat3/survivin. Stem Cells 26(1):30-34.
27. Blum B, Bar-Nur O, Golan-Lev T, Benvenisty N (2009) The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nat Biotechnol 27(3):281-287.
28. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3(8):917-921.
29. Rhee YH, et al. (2011) Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. J Clin Invest 121(6): 2326-2335.
30. Oltersdorf T, et al. (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435(7042):677-681.
31. Kuo PC, Liu HF, Chao JI (2004) Survivin and p53 modulate quercetin-induced cell growth inhibition and apoptosis in human lung carcinoma cells. J Biol Chem 279(53): 55875-55885.
32. Wong H, et al. (2009) Pharmacodynamics of 2-[4-[(1E)-1-(hydroxyimino)-2, 3-dihydro- 1H-inden-5-yl]-3-(pyridine-4-yl)-1H-pyrazol-1-yl]ethan-1-ol (GDC-0879), a potent and selective B-Raf kinase inhibitor: Understanding relationships between systemic concentrations, phosphorylated mitogen-activated protein kinase kinase 1 inhibition, and efficacy. J Pharmacol Exp Ther 329(1):360-367.
33. Lee TH, et al. (2010) Functional recapitulation of smooth muscle cells via induced pluripotent stem cells from human aortic smooth muscle cells. Circ Res 106(1): 120-128.
34. Mihara M, et al. (2003) p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11(3):577-590.
35. Adrain C, Creagh EM, Martin SJ (2001) Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. EMBO J 20(23): 6627-6636.
36. Ceballos-Cancino G, Espinosa M, Maldonado V, Melendez-Zajgla J (2007) Regulation of mitochondrial Smac/DIABLO-selective release by survivin. Oncogene 26(54): 7569-7575.
37. Song Z, Yao X, Wu M (2003) Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis. J Biol Chem 278(25):23130-23140.
38. Brooks CL, Gu W (2011) p53 regulation by ubiquitin. FEBS Lett 585(18):2803-2809.
39. Santiago A, Li D, Zhao LY, Godsey A, Liao D (2013) p53 SUMOylation promotes its nuclear export by facilitating its release from the nuclear export receptor CRM1. Mol Biol Cell, 10.1091/mbc.E12-10-0771.
40. Altieri DC (2008) Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8(1):61-70.
41. Wang T, et al. (2008) Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells. Cancer Lett 262(2):214-222.
42. Siegelin MD, Reuss DE, Habel A, Herold-Mende C, von Deimling A (2008) The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of survivin. Mol Cancer Ther 7(11):3566-3574.
43. Nakahara T, et al. (2007) YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts. Cancer Res 67(17):8014-8021.
44. Stambrook PJ (2007) An ageing question: Do embryonic stem cells protect their genomes? Mech Ageing Dev 128(1):31-35.
45. Maynard S, et al. (2008) Human embryonic stem cells have enhanced repair of multiple forms of DNA damage. Stem Cells 26(9):2266-2274.
46. Luo LZ, et al. (2012) DNA repair in human pluripotent stem cells is distinct from that in non-pluripotent human cells. PLoS ONE 7(3):e30541.
47. Zhao T, Xu Y (2010) p53 and stem cells: New developments and new concerns. Trends Cell Biol 20(3):170-175.
48. Lin T, et al. (2005) p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 7(2):165-171.
49. Mirza A, et al. (2002) Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 21(17):2613-2622.
50. Venot C, et al. (1998) The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression. EMBO J 17(16):4668-4679.
51. Wang Z, Zhang B, Yang L, Ding J, Ding HF (2008) Constitutive production of NFkappaB2 p52 is not tumorigenic but predisposes mice to inflammatory autoimmune disease by repressing Bim expression. J Biol Chem 283(16):10698-10706.
52. Matsui K, Fine A, Zhu B, Marshak-Rothstein A, Ju ST (1998) Identification of two NFkappa B sites in mouse CD95 ligand (Fas ligand) promoter: Functional analysis in T cell hybridoma. J Immunol 161(7):3469-3473.
53. Ohtsuka T, et al. (2004) ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway. Nat Cell Biol 6(2):121-128.
54. Kobayashi S, et al. (2005) 53BP2 induces apoptosis through the mitochondrial death pathway. Genes Cells 10(3):253-260.
55. Perkins CL, Fang G, Kim CN, Bhalla KN (2000) The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis. Cancer Res 60(6):1645-1653.
56. Sunayama J, et al. (2004) Physical and functional interaction between BH3-only protein Hrk and mitochondrial pore-forming protein p32. Cell Death Differ 11(7): 771-781.
57. Gressner O, et al. (2005) TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria. EMBO J 24(13):2458-2471.
58. Priyadarsini RV, et al. (2010) The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-kappaB inhibition. Eur J Pharmacol 649(1-3):84-91.
59. Heinz SA, Henson DA, Austin MD, Jin F, Nieman DC (2010) Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial. Pharmacol Res 62(3):237-242.
60. Shan BE, Wang MX, Li RQ (2009) Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/betacatenin signaling pathway. Cancer Invest 27(6):604-612.
61. Lu SJ, et al. (2008) Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood 112(12):4475-4484.
62. Leung CG, et al. (2007) Requirements for survivin in terminal differentiation of erythroid cells and maintenance of hematopoietic stem and progenitor cells. J Exp Med 204(7):1603-1611.
63. Lee JS, et al. (2009) Senescent growth arrest in mesenchymal stem cells is bypassed by Wip1-mediated downregulation of intrinsic stress signaling pathways. Stem Cells 27 (8):1963-1975.
64. Park CH, et al. (2005) In vitro and in vivo analyses of human embryonic stem cellderived dopamine neurons. J Neurochem 92(5):1265-1276.
65. Lee MY, et al. (2006) Local subplasma membrane Ca2+ signals detected by a tethered Ca2+ sensor. Proc Natl Acad Sci USA 103(35):13232-13237.
66. Vazquez-Martin A, et al. (2012) Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency. Scientific Reports 2:964.
67. Ben-David U, et al. (2013) Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. Cell Stem Cell 12(2): 167-179.